Massachusetts General Hospital The immunosuppressive tumor microenvironment remains a limiting factor for anti-cancer vaccine therapies. In addition, tumors systemically alter immune cells’ function via secretion of cytokines such as VEGF, a major proangiogenic cytokine. Hence, anti-angiogenic treatment may...